Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study

Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pre...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 14; no. 8; p. e0221084
Main Authors Mirinaviciute, Grazina, Barlinn, Regine, Gjeruldsen Dudman, Susanne, Flem, Elmira
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 13.08.2019
PLOS
Public Library of Science (PLoS)
Subjects
Adult
Age
Antibodies
Antibodies, Viral - immunology
Biology and life sciences
Birth
Chicken pox
Chickenpox
Chickenpox - epidemiology
Chickenpox - immunology
Childbirth & labor
Children
Chronology
Cohort analysis
Congenital diseases
Cross-Sectional Studies
Demographic aspects
Disease control
Disease susceptibility
Environmental health
Enzyme immunoassay
Enzymes
Epidemiology
Exposure
Female
Fever
Gestational age
Herpes zoster
Herpesvirus 3, Human - immunology
Humans
Immunity
Immunity (Physiology)
Immunoassay
Immunoglobulin G
Immunoglobulin G - immunology
Infection
Infections
Infectious diseases
Medical examination
Medicine and Health Sciences
Middle Aged
Newborn infants
Norway - epidemiology
Obstetrics
Pediatric diseases
People and Places
Population
Pregnancy
Pregnancy Complications, Infectious - immunology
Pregnant women
Public health
Rash
Registries
Screening
Seroepidemiologic Studies
Serology
Target recognition
Testing
Vaccination
Vaccines
Varicella
Varicella-zoster virus
Virology
Viruses
Womens health
Young Adult
Norway
United States > US
Online AccessGet full text

Cover

Abstract Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17-18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women's age at birth, gestational age, women's country of birth and year of child's birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
AbstractList Introduction Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. Methods We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17–18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Results Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women’s age at birth, gestational age, women’s country of birth and year of child’s birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. Conclusions The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
IntroductionInfection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age.MethodsWe determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17-18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal.ResultsOf the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women's age at birth, gestational age, women's country of birth and year of child's birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive.ConclusionsThe findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17-18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women's age at birth, gestational age, women's country of birth and year of child's birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
Introduction Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. Methods We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17–18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Results Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women’s age at birth, gestational age, women’s country of birth and year of child’s birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. Conclusions The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17-18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women's age at birth, gestational age, women's country of birth and year of child's birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. Methods We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17–18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Results Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women’s age at birth, gestational age, women’s country of birth and year of child’s birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. Conclusions The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.
Audience Academic
Author Barlinn, Regine
Mirinaviciute, Grazina
Gjeruldsen Dudman, Susanne
Flem, Elmira
AuthorAffiliation 1 Department of Infectious Diseases Epidemiology and Modeling, Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
2 Department of Microbiology, Oslo University Hospital, Oslo, Norway
Universidad Nacional de la Plata, ARGENTINA
3 Institute of Clinical Medicine, University of Oslo, Oslo, Norway
AuthorAffiliation_xml – name: Universidad Nacional de la Plata, ARGENTINA
– name: 1 Department of Infectious Diseases Epidemiology and Modeling, Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
– name: 2 Department of Microbiology, Oslo University Hospital, Oslo, Norway
– name: 3 Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Author_xml – sequence: 1
  givenname: Grazina
  orcidid: 0000-0002-2512-3328
  surname: Mirinaviciute
  fullname: Mirinaviciute, Grazina
  organization: Department of Infectious Diseases Epidemiology and Modeling, Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
– sequence: 2
  givenname: Regine
  surname: Barlinn
  fullname: Barlinn, Regine
  organization: Department of Microbiology, Oslo University Hospital, Oslo, Norway
– sequence: 3
  givenname: Susanne
  orcidid: 0000-0001-5047-4982
  surname: Gjeruldsen Dudman
  fullname: Gjeruldsen Dudman, Susanne
  organization: Institute of Clinical Medicine, University of Oslo, Oslo, Norway
– sequence: 4
  givenname: Elmira
  surname: Flem
  fullname: Flem, Elmira
  organization: Department of Infectious Diseases Epidemiology and Modeling, Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31408478$$D View this record in MEDLINE/PubMed
BookMark eNqNk1uL1DAUx4usuBf9BqIBQfBhxiRtk_RFWAYvA6sLrvoa0iTtZGiT2SSddfz0ZtzOMgUFG2ibk9-55J-c8-zEOquz7DmCc5RT9HbtBm9FN98k8xxijCArHmVnqMrxjGCYnxz9n2bnIawhLHNGyJPsNEdFoik7y5pl3w_WxB2IDmyFN1J3nQC_XIjag63xQwCid7YFG69bK2wEd67XFhgL4kqDL87f6dYICz67NPdAWAUWK9Olt1s5H8FNHNTuafa4EV3Qz8bvRfb9w_tvi0-zq-uPy8Xl1UxSROJMFbjJYV1IwnKhEKVMUSTLRilWMwYho1pIWetK5bSqCWpKpiGtESUFg6im-UX28j7upnOBjxIFjjFNA7KqTMTynlBOrPnGm174HXfC8D8G51sufDSy01ykR9ciKaWKgiAiGqyUxpqJVBYmVYr1bsw21L1WUtvoRTcJOl2xZsVbt-WEVBiSo3KlNyEay63zgqeTLDGnBSxwIl6NKby7HXSI_9jUSLUi1W1s41I62Zsg-WVZkZzQgu2zzf9CpaF0b2S6Ro1J9onDm4lDYqL-GVsxhMCXN1__n73-MWVfH7ErLbq4Cq4bonE2TMHioI8LwevmQVsE-b4LDmrwfRfwsQuS24vjc3lwOlz7_De9GgQA
CitedBy_id crossref_primary_10_3989_emerita_2019_14_1904
crossref_primary_10_3390_life13020593
crossref_primary_10_36740_WLek202109133
crossref_primary_10_11603_1681_2727_2024_2_14616
crossref_primary_10_3390_vaccines8020214
Cites_doi 10.1016/j.vaccine.2016.12.014
10.1038/sj.jp.7210599
10.1016/S1701-2163(16)35190-8
10.1111/j.1365-3016.2009.01062.x
10.1097/00006454-198509000-00013
10.1038/sj.jp.7200508
10.1016/j.jcv.2017.07.010
10.1016/S0140-6736(73)90134-7
10.1111/j.1471-0528.2004.00320.x
10.1016/j.vaccine.2010.06.004
10.1186/s12879-016-1581-4
10.1136/adc.2010.206037
10.1007/s10654-007-9136-z
10.3109/23744235.2015.1123290
10.1016/j.vaccine.2005.09.028
10.1093/ije/dyw029
10.1177/1403494811399653
10.1111/apm.12899
10.5603/GP.a2017.0003
10.1007/s00404-012-2398-z
10.1002/pd.3843
10.1111/j.1471-0528.2011.02983.x
10.1016/j.jinf.2007.02.003
10.1056/NEJM194704102361504
10.1371/journal.pone.0081881
ContentType Journal Article
Copyright COPYRIGHT 2019 Public Library of Science
2019 Mirinaviciute et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
info:eu-repo/semantics/openAccess
2019 Mirinaviciute et al 2019 Mirinaviciute et al
Copyright_xml – notice: COPYRIGHT 2019 Public Library of Science
– notice: 2019 Mirinaviciute et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: info:eu-repo/semantics/openAccess
– notice: 2019 Mirinaviciute et al 2019 Mirinaviciute et al
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
3HK
5PM
DOA
DOI 10.1371/journal.pone.0221084
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
ProQuest Nursing and Allied Health Journals
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Database‎ (1962 - current)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
NORA - Norwegian Open Research Archives
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
Technology Collection
Technology Research Database
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
DatabaseTitleList Agricultural Science Database





MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Public Health
DocumentTitleAlternate Immunity to varicella zoster virus among pregnant women in Norway
EISSN 1932-6203
Editor Hozbor, Daniela Flavia
Editor_xml – sequence: 1
  givenname: Daniela Flavia
  surname: Hozbor
  fullname: Hozbor, Daniela Flavia
ExternalDocumentID 2272720895
oai_doaj_org_article_aaaaeba084d44616af2dde2e8a8d7269
10852_74042
A596367487
10_1371_journal_pone_0221084
31408478
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Norway
United States--US
GeographicLocations_xml – name: Norway
– name: United States--US
GrantInformation_xml – fundername: ;
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
ECM
EIF
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RIG
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
AAYXX
AFPKN
CITATION
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PQEST
PQUKI
PRINS
RC3
3HK
AAPBV
ABPTK
N95
5PM
ID FETCH-LOGICAL-c716t-d42f30b4c683ad1778d71c5fdd8b880087eaccbe9d379b61f58e07b1764801b73
IEDL.DBID RPM
ISSN 1932-6203
IngestDate Sun Aug 06 00:16:12 EDT 2023
Tue Oct 22 15:15:08 EDT 2024
Tue Sep 17 21:01:28 EDT 2024
Sat Apr 29 05:42:14 EDT 2023
Thu Oct 10 20:00:46 EDT 2024
Thu Feb 22 23:24:51 EST 2024
Tue Nov 12 23:16:38 EST 2024
Thu Aug 01 19:20:00 EDT 2024
Thu Aug 01 19:58:09 EDT 2024
Tue Aug 20 22:09:41 EDT 2024
Fri Aug 23 00:34:51 EDT 2024
Wed Oct 16 00:46:33 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c716t-d42f30b4c683ad1778d71c5fdd8b880087eaccbe9d379b61f58e07b1764801b73
Notes Mirinaviciute, Grazina (2020) Infections associated with varicella-zoster virus in Norway: disease burden and healthcare resource utilization. Doctoral thesis http://urn.nb.no/URN:NBN:no-77145
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-2512-3328
0000-0001-5047-4982
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692067/
PMID 31408478
PQID 2272720895
PQPubID 1436336
PageCount e0221084
ParticipantIDs plos_journals_2272720895
doaj_primary_oai_doaj_org_article_aaaaeba084d44616af2dde2e8a8d7269
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6692067
cristin_nora_10852_74042
proquest_journals_2272720895
gale_infotracmisc_A596367487
gale_infotracacademiconefile_A596367487
gale_incontextgauss_ISR_A596367487
gale_incontextgauss_IOV_A596367487
gale_healthsolutions_A596367487
crossref_primary_10_1371_journal_pone_0221084
pubmed_primary_31408478
PublicationCentury 2000
PublicationDate 2019-08-13
PublicationDateYYYYMMDD 2019-08-13
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-08-13
  day: 13
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2019
Publisher Public Library of Science
PLOS
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: PLOS
– name: Public Library of Science (PLoS)
References EG Laforet (ref7) 1947; 236
ref13
(ref24) 2013
M Biskupska (ref42) 2017; 88
C Jespersen (ref17); 2016
L Puhakka (ref22) 2016; 48
S Norway (ref35) 2019
G Mirinaviciute (ref19) 2017
(ref39) 2015
M Marin (ref23) 2007; 56
MO Savage (ref8) 1973; 1
SR Preblud (ref9) 1985; 4
RE Harris (ref5) 1965; 25
A Passi (ref15) 2017; 35
MW McKendrick (ref4) 2007; 55
G Rimseliene (ref20) 2016; 16
E Leuridan (ref28) 2011; 29
R Barlinn (ref30) 2018; 126
RM Nilsen (ref36) 2009; 23
A Pinot de Moira (ref12) 2006; 24
A Sauerbrei (ref10) 2001; 21
L Mandelbrot (ref2) 2012; 32
A Shrim (ref1) 2012; 34
M Saadatian-Elahi (ref33) 2007; 22
J Steen (ref6) 1959; 9
S Norway (ref18) 2018
P Magnus (ref25) 2016; 45
SE Bjerke (ref16) 2011; 39
ref41
G Khandaker (ref11) 2011; 96
L Pembrey (ref14) 2013; 8
L Paltiel (ref26) 2014
R Barlinn (ref31) 2017; 94
T Vilibic-Cavlek (ref38) 2012; 286
SE Bjerke (ref37) 2011; 39
ref27
ref29
SJ Knowles (ref34) 2004; 7
(ref40) 2015
RF Lamont (ref3) 2011; 118
K Mustonen (ref43) 2001; 21
(ref32) 2015
A Alanen (ref21) 2005; 112
References_xml – year: 2013
  ident: ref24
  article-title: Book of vaccination (Vaksinasjonsboka)
– ident: ref27
  article-title: Den norske mor og barn-undersøkelsen
– volume: 35
  start-page: 570
  issue: 4
  year: 2017
  ident: ref15
  article-title: The economic impact of prenatal varicella immunity among pregnant women in Alberta
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.12.014
  contributor:
    fullname: A Passi
– year: 2015
  ident: ref40
  article-title: Varicella Zoster (chickenpox) in Pregnancy Clinical Giudeline Australia
– volume: 21
  start-page: 545
  issue: 8
  year: 2001
  ident: ref10
  article-title: Neonatal varicella
  publication-title: Journal of perinatology: official journal of the California Perinatal Association
  doi: 10.1038/sj.jp.7210599
  contributor:
    fullname: A Sauerbrei
– volume: 34
  start-page: 287
  issue: 3
  year: 2012
  ident: ref1
  article-title: Management of varicella infection (chickenpox) in pregnancy
  publication-title: Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC
  doi: 10.1016/S1701-2163(16)35190-8
  contributor:
    fullname: A Shrim
– ident: ref29
– ident: ref41
– volume: 56
  start-page: 1
  issue: RR-4
  year: 2007
  ident: ref23
  article-title: Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)
  publication-title: MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control
  contributor:
    fullname: M Marin
– volume: 23
  start-page: 597
  issue: 6
  year: 2009
  ident: ref36
  article-title: Self-selection and bias in a large prospective pregnancy cohort in Norway
  publication-title: Paediatric and perinatal epidemiology
  doi: 10.1111/j.1365-3016.2009.01062.x
  contributor:
    fullname: RM Nilsen
– year: 2017
  ident: ref19
  article-title: Varicella-Related Primary Healthcare Visits, Hospitalizations and Mortality in Norway, 2008–2014
  publication-title: The Pediatric infectious disease journal
  contributor:
    fullname: G Mirinaviciute
– year: 2019
  ident: ref35
  article-title: Immigration
  publication-title: Immigration
  contributor:
    fullname: S Norway
– volume: 4
  start-page: 503
  issue: 5
  year: 1985
  ident: ref9
  article-title: Deaths from varicella in infants
  publication-title: Pediatric infectious disease
  doi: 10.1097/00006454-198509000-00013
  contributor:
    fullname: SR Preblud
– volume: 21
  start-page: 141
  issue: 2
  year: 2001
  ident: ref43
  article-title: Congenital varicella-zoster virus infection after maternal subclinical infection: clinical and neuropathological findings
  publication-title: Journal of perinatology: official journal of the California Perinatal Association
  doi: 10.1038/sj.jp.7200508
  contributor:
    fullname: K Mustonen
– volume: 94
  start-page: 57
  year: 2017
  ident: ref31
  article-title: High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway
  publication-title: Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology
  doi: 10.1016/j.jcv.2017.07.010
  contributor:
    fullname: R Barlinn
– volume: 1
  start-page: 352
  issue: 7799
  year: 1973
  ident: ref8
  article-title: Maternal varicella infection as a cause of fetal malformations
  publication-title: Lancet
  doi: 10.1016/S0140-6736(73)90134-7
  contributor:
    fullname: MO Savage
– volume: 112
  start-page: 50
  issue: 1
  year: 2005
  ident: ref21
  article-title: Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland
  publication-title: BJOG: an international journal of obstetrics and gynaecology
  doi: 10.1111/j.1471-0528.2004.00320.x
  contributor:
    fullname: A Alanen
– volume: 29
  start-page: 2222
  issue: 11
  year: 2011
  ident: ref28
  article-title: Kinetics of maternal antibodies against rubella and varicella in infants
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.06.004
  contributor:
    fullname: E Leuridan
– volume: 16
  start-page: 254
  year: 2016
  ident: ref20
  article-title: Varicella-zoster virus susceptibility and primary healthcare consultations in Norway
  publication-title: BMC infectious diseases
  doi: 10.1186/s12879-016-1581-4
  contributor:
    fullname: G Rimseliene
– volume: 96
  start-page: 453
  issue: 5
  year: 2011
  ident: ref11
  article-title: Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia
  publication-title: Archives of disease in childhood
  doi: 10.1136/adc.2010.206037
  contributor:
    fullname: G Khandaker
– ident: ref13
– volume: 22
  start-page: 405
  issue: 6
  year: 2007
  ident: ref33
  article-title: Seroprevalence of varicella antibodies among pregnant women in Lyon-France
  publication-title: European journal of epidemiology
  doi: 10.1007/s10654-007-9136-z
  contributor:
    fullname: M Saadatian-Elahi
– volume: 7
  start-page: 344
  issue: 4
  year: 2004
  ident: ref34
  article-title: Susceptibility to infectious rash illness in pregnant women from diverse geographical regions
  publication-title: Communicable disease and public health / PHLS
  contributor:
    fullname: SJ Knowles
– volume: 48
  start-page: 406
  issue: 5
  year: 2016
  ident: ref22
  article-title: Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012
  publication-title: Infectious diseases
  doi: 10.3109/23744235.2015.1123290
  contributor:
    fullname: L Puhakka
– volume: 24
  start-page: 1298
  issue: 9
  year: 2006
  ident: ref12
  article-title: The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.09.028
  contributor:
    fullname: A Pinot de Moira
– volume: 45
  start-page: 382
  issue: 2
  year: 2016
  ident: ref25
  article-title: Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa)
  publication-title: International journal of epidemiology
  doi: 10.1093/ije/dyw029
  contributor:
    fullname: P Magnus
– start-page: 29
  year: 2014
  ident: ref26
  article-title: The biobank of the Norwegian Mother and Child Cohort Study–present status
  publication-title: Norsk Epidemiologi
  contributor:
    fullname: L Paltiel
– year: 2018
  ident: ref18
  article-title: Population in Norway Statistics Norway, Oslo
  publication-title: Population in Norway Statistics Norway, Oslo
  contributor:
    fullname: S Norway
– volume: 39
  start-page: 464
  issue: 5
  year: 2011
  ident: ref37
  article-title: Infectious immune status in an obstetric population of Pakistani immigrants in Norway
  publication-title: Scandinavian journal of public health
  doi: 10.1177/1403494811399653
  contributor:
    fullname: SE Bjerke
– volume: 39
  start-page: 464
  issue: 5
  year: 2011
  ident: ref16
  article-title: Infectious immune status in an obstetric population of Pakistani immigrants in Norway
  publication-title: Scandinavian journal of public health
  doi: 10.1177/1403494811399653
  contributor:
    fullname: SE Bjerke
– volume: 9
  start-page: 36
  year: 1959
  ident: ref6
  article-title: Varicella in a newborn girl
  publication-title: Journal of Oslo City Hospital
  contributor:
    fullname: J Steen
– volume: 126
  start-page: 899
  issue: 12
  year: 2018
  ident: ref30
  article-title: Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study
  publication-title: APMIS: acta pathologica, microbiologica, et immunologica Scandinavica
  doi: 10.1111/apm.12899
  contributor:
    fullname: R Barlinn
– volume: 2016
  start-page: 1
  ident: ref17
  article-title: Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up
  publication-title: Epidemiology and infection
  contributor:
    fullname: C Jespersen
– volume: 88
  start-page: 13
  issue: 1
  year: 2017
  ident: ref42
  article-title: Varicella—a potential threat to maternal and fetal health
  publication-title: Ginekol Pol
  doi: 10.5603/GP.a2017.0003
  contributor:
    fullname: M Biskupska
– volume: 286
  start-page: 901
  issue: 4
  year: 2012
  ident: ref38
  article-title: Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing
  publication-title: Archives of gynecology and obstetrics
  doi: 10.1007/s00404-012-2398-z
  contributor:
    fullname: T Vilibic-Cavlek
– volume: 32
  start-page: 511
  issue: 6
  year: 2012
  ident: ref2
  article-title: Fetal varicella—diagnosis, management, and outcome
  publication-title: Prenatal diagnosis
  doi: 10.1002/pd.3843
  contributor:
    fullname: L Mandelbrot
– volume: 118
  start-page: 1155
  issue: 10
  year: 2011
  ident: ref3
  article-title: Varicella-zoster virus (chickenpox) infection in pregnancy
  publication-title: BJOG: an international journal of obstetrics and gynaecology
  doi: 10.1111/j.1471-0528.2011.02983.x
  contributor:
    fullname: RF Lamont
– volume: 55
  start-page: 64
  issue: 1
  year: 2007
  ident: ref4
  article-title: VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention
  publication-title: The Journal of infection
  doi: 10.1016/j.jinf.2007.02.003
  contributor:
    fullname: MW McKendrick
– year: 2015
  ident: ref39
  article-title: External review against programme appraisal criteria for the UK National Screening Committee (UK NSC)
– volume: 25
  start-page: 734
  year: 1965
  ident: ref5
  article-title: Varicella Pneumonia Complicating Pregnancy
  publication-title: Report of a Case and Review of Literature. Obstetrics and gynecology
  contributor:
    fullname: RE Harris
– volume: 236
  start-page: 534
  issue: 15
  year: 1947
  ident: ref7
  article-title: Multiple congenital defects following maternal varicella; report of a case
  publication-title: The New England journal of medicine
  doi: 10.1056/NEJM194704102361504
  contributor:
    fullname: EG Laforet
– volume: 8
  start-page: e81881
  issue: 11
  year: 2013
  ident: ref14
  article-title: Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study
  publication-title: PloS one
  doi: 10.1371/journal.pone.0081881
  contributor:
    fullname: L Pembrey
– year: 2015
  ident: ref32
  article-title: Varicella vaccination in the European Union
SSID ssj0053866
Score 2.3701227
Snippet Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination...
Introduction Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and...
IntroductionInfection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and...
Introduction Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and...
SourceID plos
doaj
pubmedcentral
cristin
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0221084
SubjectTerms Adult
Age
Antibodies
Antibodies, Viral - immunology
Biology and life sciences
Birth
Chicken pox
Chickenpox
Chickenpox - epidemiology
Chickenpox - immunology
Childbirth & labor
Children
Chronology
Cohort analysis
Congenital diseases
Cross-Sectional Studies
Demographic aspects
Disease control
Disease susceptibility
Environmental health
Enzyme immunoassay
Enzymes
Epidemiology
Exposure
Female
Fever
Gestational age
Herpes zoster
Herpesvirus 3, Human - immunology
Humans
Immunity
Immunity (Physiology)
Immunoassay
Immunoglobulin G
Immunoglobulin G - immunology
Infection
Infections
Infectious diseases
Medical examination
Medicine and Health Sciences
Middle Aged
Newborn infants
Norway - epidemiology
Obstetrics
Pediatric diseases
People and Places
Population
Pregnancy
Pregnancy Complications, Infectious - immunology
Pregnant women
Public health
Rash
Registries
Screening
Seroepidemiologic Studies
Serology
Target recognition
Testing
Vaccination
Vaccines
Varicella
Varicella-zoster virus
Virology
Viruses
Womens health
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQSkhcEOVrUwpYCAk4pI3jxHaOpaJqkSgSUNSbZcf2diWUrJJsUfn1jB3vqkGV4ECO8eSQmTfjcTLzBqHXxPGC5bVImQufbihJFSl1Si1xjBLjBzL6aoszdnJefLwoL26M-vI1YSM98Ki4AwWX1SoThYGTC2HK5eCRuRVKGJ6zsXUvqzaHqTEGgxczFhvlKCcH0S77q7ax-7BrkcBmercOftRMtqTA3L-Nz7PVj7a_Lfn8s4byxqZ0_ADdj9kkPhzfYgfdsc1DtBP9tcdvI6n0u0fInYZGkOEaDy2-Up5KCACAf_kejw5fLbt1j8PgIbzq7MJXx-BAzoCXDYYcEZ-13U-7ACzhT6FnC6vG4MCLjI_aS8jhsa9IvH6Mzo8_fDs6SeOMhbSGk9KQmiJ3NNNFzQRVhnAOWiV16YwRGlw7Exwic61tZSivNCOuFDbjmnDmeWc0p0_QrAGtzhE2jKs8oyqvXVWwshYEHi1ZpU0hSKGyBM2jwmUD8PbUpGUueQFhI0HpxgJyNbJsyPCrjcPpZFSl9LaT0XYJeu_NtJX1HNnhBiBHRuTIvyEnQS-9keXYcLr1dHlYQlDyM1h4gl4FCc-T0fhCnIVa9708_fz9H4S-fpkIvYlCrgW41Co2P8A7ef6tieTeRBK8vZ4szz0kN1rpZZ6HX-miKuHJDUxvX346InarNQqHa0hORIL4BMsTtU5XmuVloCBnrPK8_7v_ww7P0D3IQiv_oZ7QPTQburV9DpneoF8Ep_4NmAtSDw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegCAkJITZgDQywEBLwkK2OE9t5QmOibEgMCRjam-XYSVcJJSVph8Zfz53jFoImRB_ji6rcl8_nu98R8pxVMhWJVbGofOqGs9iwrIh5ySrBmcOBjFhtcSKOTtP3Z9lZSLh1oaxy7RO9o3aNxRz5fpL4K0OVZ68X32OcGoW3q2GExnVygyVS4uFLTd-tPTHYshChXY5Lth-ks7do6nIP9i7mMU1vWm9N9WBj8vj9Gy89WnxruqtC0L8rKf_YmqZ3yZ0QU9KDXgm2yLWy3ia3-4Qc7fuMtslWsOKOvgxQ06_ukerYt4csL-myoRcGAYZALehP7Pxo6cW8XXXUjyOii7acYc0M9ZANdF5TiBzpSdP-KGegYfSD7-SipnbUoyXTw-YcInuKdYqX98np9O2Xw6M4TF6ILZyflrFLk4pPitQKxY1jUionmc0q51QBBj9REvy1LcrccZkXglWZKieyYFIgGk0h-QMyqoHLY0KdkCaZcJPYKk9FZhWDVzORFy5VLDWTiIyDAHQNSo-ApVmiZQrOJCLxWiJ60WNvaH8BJ-HM0rNWoyx1kGVE3qDYNrSInO0fNO1MB0PUBn5lYYDcwUmYCVMl4OGTUhn4xkTkEXmKQtd9G-rG_vVBBq4KJ7PIiDzzFIieUWN5zsysuk4ff_z6H0SfPw2IXgSiqgH1sSa0RMA3ISrXgHJ3QAk-wA6Wx6iia650-re1wJtrtb16eafX4A3XOBy5IWRREZED3R6wdbhSz889MLkQOU4DePjvv3xEbkHUmWNinvFdMlq2q_IxRHbL4ok331-1REz_
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGeeEFMb6aMcBCSMBDqthxbOcBoTExbUgMCSjam-V8dZWmpCTpoPz13LluRVAR9DE-V8p9-S6--x0hz1mlhOS5DmXlPt3ELLQsycK4ZJWMWYEDGbHa4lyeTsX7i-Rij2xmtnoGdjtTO5wnNW2vJj--rd6Awb92UxsU22yaLJq6nMCZxCItbpCbXECujsV8YnuvANbtbi8xagklj2LfTPe3f4GgOHe2Vg-OLYfuv_Xho8VV0-0KUP-ss_zt4Dq5Q277iJMerVVkn-yV9V2y7226oy898PSre6Q6c80i_Yr2Db22CDcESkJ_Yh9IS6_n7bKjbjgRXbTlDCtoqANwoPOaQhxJz5v2ezkDfaMfXF8XtXVBHXYyPW4ugcUUqxZX98n05N2X49PQz2EIc8im-rAQvIqjTORSx7ZgSulCsTypikJnYP6RVuC986xMi1ilmWRVostIZUxJxKbJVPyAjGrg6pjQQioLbLc8r1Ihk1wz2JrINCuEZsJGARl7hpsaTADhSxNulADXEpBwIwGzWCNxGHcdpyCDWbPSoOyMl11A3qKYtrSIo-0eNO3MeLM0Fn5lZoG8gLyYSVtx8Pe81Bbekcs0IE9RyGbdlLr1BuYoAceFc1pUQJ45CsTSqLFYZ2aXXWfOPn79D6LPnwZELzxR1YC65NY3SMA7IUbXgPJwQAkeIR8sj1ElN1zpDOfuul2nCezcqOnu5Ydrjd1yLYYEHAIYHRA10OUBW4cr9fzSwZRLmeJsgIN_svARuQVhaIpf6ll8SEZ9uywfQ6jXZ0-c9f4C6CdQ0g
  priority: 102
  providerName: Scholars Portal
Title Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study
URI https://www.ncbi.nlm.nih.gov/pubmed/31408478
https://www.proquest.com/docview/2272720895
http://hdl.handle.net/10852/74042
https://pubmed.ncbi.nlm.nih.gov/PMC6692067
https://doaj.org/article/aaaaeba084d44616af2dde2e8a8d7269
http://dx.doi.org/10.1371/journal.pone.0221084
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2cuGCGF_NGMVCSMAhbZwP2zlu1cqG1DINhnqzHCfpKm1JlLRD46_n2XEqgnZA9OBD_Swl78vvOe_9jNB7krOQ-oq7NDdHNwFxJYkSN8hITgOS6gsZdbXFgp5dhV-W0XIPRV0vjCnaV8l6XNzcjov1tamtrG7VpKsTm1zMp5TGGnV8so_2QUG7FL11v2DAlNoeuYCRiRXJuCqLbAwbFvG4vosngMQCHDOHsFcZayp6G5PB79956UF1UzYPhaB_V1L-sTXNnqInNqbEx-2zH6C9rHiGDqzVNvijhZb-9Bzl56YdZHOPNyW-kxpQCNQA_9KdHjW-W9fbBpvrh3BVZytdI4MNRANeFxgiRbwo65_ZCjQKz03nFpZFig06Mp6W1xDJY12XeP8CXc1Ov0_PXHvTgqsgX9q4aejngZeEivJApoQxnjKiojxNeQIG7nEG_lklWZwGLE4oySOeeSwhjGr0mYQFL9GgAAYPEU4pk74XSF_lcUgjxQksjWicpCEnofQcNLQMFwUouQYojXzBQnAeDnI7CYiqxdoQ5oMbgxylZaXQYhRWjA460WLa0WqkbPNHWa-E1Rch4ZclEshTyHwJlbkPHt3PuIR39GnsoLdayKJtO93ZuziOwDXpm1iYg94ZCo2WUehynJXcNo04__rjH4i-XfaIPliivAR1UdK2QMA7aRSuHuVRjxJsXvWmh1olO640wvfNB3UeR7CyU9OHp1-1GrvjWmcJDmI9Xe6xtT8DdmmAyK0dHv73ytfoMQSgsT6jJ8ERGmzqbfYGgrxNMgLTXjIY-ZTocfZ5hB6dnC4uLkfm2ATGechHxvR_A1ZOVwQ
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12068,12235,12777,21400,24330,27936,27937,31731,33278,33385,33756,43322,43591,43612,43817,53804,53806,74073,74342,74363,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegCIGEEBuMBgazEBLwkC3Oh-08oVExtbAVCTa0N8uJk64SSkrSDo2_njvHLQRNiD7GF1W5L5_Pd78j5CUrRczDXPq8tKmbiPmaJZkfFazkETM4kBGrLaZ8fBZ_OE_OXcKtdWWVa59oHbWpc8yRH4ShvTKUafJ28d3HqVF4u-pGaNwkt2DbT9Ew5WhT4gG2zLlrl4sEO3DS2V_UVbEPexezmKa3c2tNVW9jsvj9Gy89WHyr2-tC0L8rKf_Ymo4ekPsupqSHnRJskRtFtU3udQk52vUZbZMtZ8Utfe2gpt88JOXEtocsr-iyppcaAYZALehP7Pxo6OW8WbXUjiOii6aYYc0MtZANdF5RiBzptG5-FDPQMHpiO7morgy1aMl0VF9AZE-xTvHqETk7en86Gvtu8oKfw_lp6Zs4LKMgi3MuI22YENIIlielMTIDgw-kAH-dZ0VqIpFmnJWJLAKRMcERjSYT0Q4ZVMDlIaGGCx0GkQ7zMo15kksGryY8zUwsWawDjwydAFQFSo-ApUmoRAzOxCP-WiJq0WFvKHsBJ-DM0rFWoSyVk6VH3qHYNrSInG0f1M1MOUNUGn5FpoHcwEmYcV2G4OHDQmr4xpCnHtlDoauuDXVj_-owAVeFk1mER15YCkTPqLA8Z6ZXbasmn77-B9GXzz2iV46orEF9cu1aIuCbEJWrR7nbowQfkPeWh6iia6606re1wJtrtb1--XGnwRuuRXDkhpBFekT0dLvH1v5KNb-wwOScpzgN4Mm__3KP3Bmfnhyr48n041NyFyLQFJP0LNolg2WzKp5BlLfMnltT_gUMWE-1
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwELegCISEEBuPBgazEBLwIWuch-18QqNQrTwKAob2zXLipKuEkpK0Q-Ov585xC0ETIh_js6Lcy2f77neEPGGliHmYS5-X9ugmYr5mSeZHBSt5xAw2ZMRsixk_Oo7fnCQnLv-pdWmVG59oHbWpczwjH4WhvTKUaTIqXVrEx1eTF8vvPnaQwptW107jMrkCq2KM3QzkeJvuAXbNuSudiwQbOUkdLOuqOIB1jFl806u5tayqt0hZLP-txx4sv9XtReHo31mVfyxTk1vkposv6WGnEDvkUlHtkhvd4Rztao52yY6z6JY-c7DTz2-TcmpLRVbndFXTM41gQ6Ai9CdWgTT0bNGsW2pbE9FlU8wxf4Za-Aa6qChEkXRWNz-KOWgbfW-ruqiuDLXIyXRcn0KUTzFn8fwOOZ68_jI-8l0XBj-HvdTKN3FYRkEW51xG2jAhpBEsT0pjZAbGH0gBvjvPitREIs04KxNZBCJjgiMyTSaiu2RQAZeHhBoudBhEOszLNOZJLhlMTXiamViyWAceGToBqAoMAMFLk1CJGByLR_yNRNSyw-FQ9jJOwP6lY61CWSonS4-8RLFtaRFF276om7lyRqk0PEWmgdzArphxXYbg7cNCavjHkKce2Uehq64kdesL1GECbgu7tAiPPLYUiKRRoU7O9bpt1fTD1_8g-vypR_TUEZU1qE-uXXkE_BMidPUo93qU4A_y3vAQVXTDlVb9thyYuVHbi4fvdRq85VoE228IX6RHRE-3e2ztj1SLUwtSznmKnQHu__uT--QaWLF6N529fUCuQzCa4nk9i_bIYNWsi4cQ8K2yR9aSfwHklVPk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunity+to+varicella+zoster+virus+among+pregnant+women+in+the+Norwegian+Mother+and+Child+Cohort+Study&rft.jtitle=PloS+one&rft.au=Barlinn%2C+Regine&rft.au=Mirinaviciute%2C+Grazina&rft.au=Flem%2C+Elmira&rft.au=Gjeruldsen+Dudman%2C+Susanne&rft.date=2019-08-13&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=14&rft.issue=8&rft.spage=e0221084&rft_id=info:doi/10.1371%2Fjournal.pone.0221084&rft.externalDBID=n%2Fa&rft.externalDocID=A596367487
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon